USPH Stock US Physical Therapy (USPH, $83.72) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 2, 2026
GET DAILY SIGNALSat Tickeron.com
This is a Bearish indicator signaling USPH's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 42 similar cases where USPH's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:
USPH in downward trend: price may decline as a result of having broken its higher Bollinger Band on October 22, 2026
USPH broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In 26 of the 35 cases the stock fell afterwards. This puts the odds of success at 74%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for USPH moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 27 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where USPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on USPH as a result. In 55 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for USPH just turned positive on October 22, 2026. Looking at past instances where USPH's MACD turned positive, the stock continued to rise in 28 of 42 cases over the following month. The odds of a continued upward trend are 67%.
Following a +2.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where USPH advanced for three days, in 217 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 159 of 254 cases where USPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. USPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.951) is normal, around the industry mean (204.132). USPH's P/E Ratio (521.941) is considerably higher than the industry average of (18.957). Projected Growth (PEG Ratio) (2.823) is also within normal values, averaging (2.498). Dividend Yield (0.021) settles around the average of (0.100) among similar stocks. P/S Ratio (1.556) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. USPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.